Product Details

Komboglyze

Saxagliptin + Metformin
2.5 mg + 850 mg
Tablet


DIN/PIN/NPN

02389177

Manufacturer

AstraZeneca

Formulary Listing Date

2014-11-27  

Unit Price

1.4115

Amount MOH Pays

1.4115

Coverage Status

General Benefit Insulin or Oral Hypoglycemic Product

ODB Formulary Therapeutic Classification

Therapeutic Note

Saxagliptin + Metformin 2.5 mg + 850 mg Tablet: Treatment of Type 2 diabetes in patients on maximally tolerated doses of metformin who have: . Inadequate glycemic control (defined as HbA1c greater than 0.07) and intolerance or contraindication to a sulfonylurea; OR . Inadequate glycemic control (HbA1c greater than 0.07) and on maximal doses of sulfonylurea and for whom insulin is not an option.

ATC Code

A10BD10

Interchangeable Products

NO  

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph